Results 161 to 170 of about 10,088 (188)

Crystal structure and Hirshfeld surface analysis of (1H-imidazole-κN³)[4-methyl-2-({[2-oxido-5-(2-phenyl-diazen-1-yl)phen-yl]methyl-idene}amino)penta-noate-κ³O,N,O']copper(II). [PDF]

Acta Crystallogr E Crystallogr Commun
Kaneda A, Suzuki S, Nakane D, Kashiwagi Y, Akitsu T.   +4 more
europepmc   +1 more source

[Status of Tuberculosis Vaccines Development in Clinical Trials]. [PDF]

Jugan Geongang Gwa Jilbyeong
Shin E, Kim SM, Yun JS, Park SH, Jeong HS, Kim YJ.   +5 more
europepmc   +1 more source

UPLC-HRMS-MS profiling of Ludwigia adscendens subsp. diffusa aerial parts and investigation of the anti-inflammatory effect. [PDF]

Sci Rep
Shawky EM, Hamdy R, Elgindi MR, Baky MH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A stochastic modeling study of H56 block in Daqingzijing oilfield

Arabian Journal of Geosciences, 2015
After years of water injection, the underground movement of oil and water in Daqingzijing oilfield is becoming more and more complex, and the distribution of reservoir parameters between wells and remaining oil is difficult to predict. The reservoir geological model of H56 block in Daqingzijing oilfield is established with the support of numerous data ...
Jianpeng Hou, Fang Ding, Weilu Li
openaire   +1 more source

MPEC 2023-H56 : 2023 HU

2023
The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

The Physical Stability of the Recombinant Tuberculosis Fusion Antigens H1 and H56

Journal of Pharmaceutical Sciences, 2013
The recombinant fusion proteins hybrid 1 [H1 (Ag85B-ESAT-6)] and hybrid 56 [H56 (Ag85B-ESAT-6-Rv2660c)] derived from Mycobacterium tuberculosis are promising antigens for subunit vaccines against tuberculosis. Both antigens are early batches of antigens to be enrolled in human clinical trials and it is therefore important to characterize their ...
Hamborg, Mette, Kramer, Ryan, Schanté, Carole E, Agger, Else Marie, Christensen, Dennis, Jorgensen, Lene, Foged, Camilla, Middaugh, C Russell   +7 more
openaire   +3 more sources

Immunogenicity of TB vaccine H56 in non-human primates (VAC4P.1113)

The Journal of Immunology, 2015
Abstract Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health problem. Several TB vaccine candidates are currently in various stages of development and clinical testing, including the protein subunit vaccine H56, from Statens Serum Institute (Copenhagen, Denmark).
Eileen Wong, Else Agger, Peter Andersen, JoAnne Flynn   +3 more
openaire   +1 more source

H56 Driving performance of huntington’s disease gene carriers

Clinical care and clinical services, 2018
Background In patients with Huntington’s disease (HD), instrumental daily activities such as working and driving become affected at a relatively young age. For most patients, the decision to quit driving is difficult and affects their independence and social activities.
Milou Jacobs, Ellen P Hart, Yuri Mejia Miranda, Geert Jan Groeneveld, Joop MA van Gerven, Raymund AC Roos   +5 more
openaire   +1 more source

Antiarrhythmic Properties of Stereoisomers of a Beta-adrenergic Blocking Agent (H56/28)

Anesthesiology, 1968
Cardiac arrhythmias were produced in the cat by inhalation of 1 per cent halopropane, 10 per cent CO2 and 89 per cent O2 and also by injection of epinephrine during inhalation of 1 per cent halopropane and 99 per cent O2. Dextro-H56/28, which has local anesthetic properties but only 1/40th the beta receptor blocking activity of the levo form of H56/28,
C O, Lord, R L, Katz, K E, Eakins
openaire   +2 more sources

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial

American Journal of Respiratory and Critical Care Medicine, 2019
Global tuberculosis (TB) control requires effective vaccines in TB-endemic countries, where most adults are infected with Mycobacterium tuberculosis (M.tb).We sought to define optimal dose and schedule of H56:IC31, an experimental TB vaccine comprising Ag85B, ESAT-6, and Rv2660c, for M.tb-infected and M.tb-uninfected adults.We enrolled 98 healthy, HIV ...
Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Michele Tameris, Soren T. Hoff, Zhongkai Shi, Dereck Tait, Ingrid Kromann, Morten Ruhwald, Kathryn Tucker Rutkowski, Barbara Shepherd, David Hokey, Ann M. Ginsberg, Willem A. Hanekom, Peter Andersen, Thomas J. Scriba, Mark Hatherill, Rachel Elizabeth Oelofse, Lynnett Stone, Anne Marie Swarts, Raida Onrust, Gail Jacobs, Lorraine Coetzee, Gloria Khomba, Bongani Diamond, Alessandro Companie, Ashley Veldsman, Humphrey Mulenga, Yolundi Cloete, Marcia Steyn, Hadn Africa, Lungisa Nkantsu, Erica Smit, Janelle Botes, Nicole Bilek, Simbarashe Mabwe   +35 more
openaire   +2 more sources